Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Somatomedins].

D Chevenne1

  • 1Hôpital Robert-Debré, Service de Biochimie-Hormonologie, Paris.

Annales De Biologie Clinique
|January 1, 1991
PubMed
Summary
This summary is machine-generated.

Insulin-like growth factors (IGFs) I and II are crucial for cellular growth and differentiation. IGF I is vital for skeletal growth and its blood levels aid in diagnosing growth disorders, while IGF II

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Plasminogen activator inhibitor type-1 is an independent marker of metabolic disorders in young adults born small for gestational age.

Journal of thrombosis and haemostasis : JTH·2010
Same author

Independent effects of weight gain and fetal programming on metabolic complications in adults born small for gestational age.

Diabetologia·2010
Same author

Medullary thyroid carcinoma identified within the first year of life in children with hereditary multiple endocrine neoplasia type 2A (codon 634) and 2B.

European journal of endocrinology·2009
Same author

Birth weight and long-term metabolic outcomes: does the definition of smallness matter?

Hormone research·2008
Same author

Impact of fetal growth restriction on body composition and hormonal status at birth in infants of small and appropriate weight for gestational age.

European journal of endocrinology·2007
Same author

Inter-method variability in PTH measurement: implication for the care of CKD patients.

Kidney international·2006
Same journal

[The role of the heart-on-a-chip to drug evaluation].

Annales de biologie clinique·2026
Same journal

A morphology-driven proof-of-concept study linking interphase nuclear abnormalities to dicentric-mediated genomic instability.

Annales de biologie clinique·2026
Same journal

Analytical validation and clinical concordance of Diazyme free light chain assays on the Cobas® platform compared with Freelite™.

Annales de biologie clinique·2026
Same journal

Small-cell secondary plasma cell leukemia mimicking low-grade B-cell lymphoma.

Annales de biologie clinique·2026
Same journal

[Multiple myeloma and analytical discrepancy in serum free light chain assay: a case report].

Annales de biologie clinique·2026
Same journal

[Summary of the 34th National Conference of the National College of Hospital Biochemistry].

Annales de biologie clinique·2026
See all related articles

Area of Science:

  • Endocrinology and Molecular Biology
  • Focuses on somatomedins or insulin-like growth factors (IGFs).
  • Explores the structure, synthesis, and function of IGFs and their binding proteins.

Context:

  • IGFs (IGF I and IGF II) are polypeptides homologous to proinsulin.
  • Synthesized mainly by the liver and other tissues, circulating bound to specific binding proteins (IGFBPs).
  • IGFBP3 carries most blood IGFs, stimulated by growth hormone (hGH), while IGFBP1 increases with hGH deficiency.

Purpose:

  • To elucidate the roles of IGF I and IGF II in human physiology.
  • To describe the characteristics and functions of various IGF binding proteins (IGFBPs) and receptors.
  • To highlight the clinical utility of IGF I measurements in diagnosing growth-related disorders.

Summary:

  • IGF I is essential for skeletal growth, with its blood levels clinically significant for diagnosing growth disorders, acromegaly, and hGH deficiency.

Related Experiment Videos

  • IGF II, while promoting cellular growth and differentiation, does not significantly impact skeletal growth and is less influenced by hGH.
  • Two main receptors exist: Type 1 (similar to insulin receptor, mediates IGF I action) and Type 2 (binds IGF II preferentially, homology to mannose-6-phosphate receptor).

    • Impact:

    • Provides a comprehensive overview of IGFs, IGFBPs, and receptors, crucial for understanding growth regulation.
    • Establishes the clinical significance of IGF I levels in diagnosing endocrine and growth disorders.
    • Underscores the potential importance of IGFs in fetal development and cellular processes.